Dr. Thorsten Schmidt

Dr. Thorsten Schmidt joined Sanofi in 2002. He is currently the Head of the Large Molecule Research team in Frankfurt. He is in this role since 2016 and he currently managing a team of around 65 people working on the design, the production and the analysis of next generation biotherapeutics. Prior to this role he was a cluster head in the disease area diabetes (GI Endocrinology) and in several positions and locations within the different Sanofi organizations.

Dr. Thorsten Schmidt studied Human Biology and received his Ph. D. degree in Biochemistry and Molecular Biology from the University of Marburg. He pursued his post-doctoral training at the university hospital in Essen and started his industrial career at Bayer AG in 1999 in the Infectious Disease unit.